A9542 is a valid 2023 HCPCS Code that could be used to indicate Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries for reimbursement purposes.
A9542 belongs to Diagnostic Radiology Type of Service and has been in effect since Jan 01, 2006.
In111 ibritumomab, dx
A9542 code information
| HCPCS code: | A9542 |
| Description: | INDIUM IN-111 IBRITUMOMAB TIUXETAN, DIAGNOSTIC, PER STUDY DOSE, UP TO 5 MILLICURIES |
| Effective Date: | Jan 01, 2006 |
| Added Date: | Jan 01, 2006 |
| Termination Date: | HCPCS A9542 was terminated on Nov 30, -0001 |
| Pricing indicator: | 51 - DRUGS |
| Multi Pricing indicator: | A - NOT APPLICABLE AS HCPCS PRICED UNDER ONE METHODOLOGY |
| Coverage code: | C - CARRIER JUDGMENT |
| BETOS code: | I1E - STANDARD IMAGING - NUCLEAR MEDICINE |
| Action code: | N - NO MAINTENANCE FOR THIS CODE |
| Type of Service: |
4 - DIAGNOSTIC RADIOLOGY
|
| Anesthesia BUQ: | 0 |
Below a selection of HCPCS codes related to A9542